Evidence map›Paper›PMID 42196234›Full record

ArticleInternational journal of molecular sciences2026

An Integrated Machine-Learning and Reverse Network-Pharmacology Pipeline Reveals

Yuan Cai, Xiaolong Feng, Xinru Tao, Penghui Li, Jiaqin Liu, Ping'an Liu, Mengxiong Xiao

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yuan CaiHunan Academy of Chinese Medicine, Changsha 410013, China.ORCID 0000-0002-5494-5523
Xiaolong FengHunan Academy of Chinese Medicine, Changsha 410013, China.
Xinru TaoHunan Academy of Chinese Medicine, Changsha 410013, China.ORCID 0009-0007-9771-4868
Penghui LiHunan Academy of Chinese Medicine, Changsha 410013, China.
Jiaqin LiuHunan Academy of Chinese Medicine, Changsha 410013, China.
Ping'an LiuHunan Academy of Chinese Medicine, Changsha 410013, China.
Mengxiong XiaoExperimental Research Center, China Academy of Chinese Medical Sciences, Beijing 100700, China.

Funding

Department of Science and Technology of Hunan Province 2023JJ60459Health Commission of Hunan Province D202303109387Hunan Provincial Administration of Traditional Chinese Medicine B2023090
6 · The paper itself

Abstract

Chronic kidney disease (CKD) lacks highly specific early diagnostic biomarkers and safe, effective therapeutic options. To address this, we integrated multi-cohort transcriptomics, bioinformatics, and machine learning with reverse network pharmacology, molecular docking, molecular dynamics simulations, and in vivo experiments to identify candidate biomarkers associated with CKD and candidate therapeutic compounds for CKD. Our analyses of the GSE175759 training set and external validation datasets (GSE37171 and GSE66494) using differential expression and WGCNA indicated that CKD is characterized by immune-inflammatory activation and suppressed energy metabolism. Integration of PPI analysis with three machine learning algorithms identified

Indexed as

Complement C3Machine LearningMAP Kinase Signaling SystemNetwork PharmacologyProto-Oncogene Proteins c-junRenal Insufficiency, ChronicResveratrolAnimalsBiomarkersFibrosisHumansMaleMolecular Docking SimulationMolecular Dynamics SimulationRatsBiomarkersComplement C3Proto-Oncogene Proteins c-junResveratrolC3chronic kidney diseaseimmune inflammationJUNMAPK/JNKresveratrol

Identifiers

PMID42196234
PMCPMC13206790

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.